Zdrowie i gospodarka · 24/11/2000

FDA Proposes to Revoke Regulation for Digoxin Products for Oral Use

The FDA is proposing to revoke the regulation that establishes conditions for marketing digoxin products for oral use, as these products can be regulated under the approval process for new drug applications and abbreviated new drug applications, as set forth in the Federal Food, Drug, and Cosmetic Act.